Rein TherapeuticsRNTX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 28 institutions reported holding Rein Therapeutics Inc. (RNTX) in their 13F filings, up 5 from Q1 2024. 9 opened new positions and 4 sold out. The largest holders were University of Texas/Texas Am Investment Management Co. ($4.9M), Alyeska Investment Group, L.P. ($1.5M) and Vanguard Group Inc. ($1.4M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Rein Therapeutics Inc.
- Filed as
- AILERON THERAPEUTICS INC (Q2 2024)
- CUSIP
- 00887A204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $8.9M |
| Exits | 4 | $5.6M |
All 13F filers, Q1 2024 → Q2 2024: 4,071,101 shares bought and 864,882 shares sold, net +3,206,219 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| University of Texas/Texas Am Investment Management Co. | 0.96% | New | 1,777,827 | $4.9M |
| Alyeska Investment Group, L.P. | 0.01% | New | 540,000 | $1.5M |
| Vanguard Group Inc. | 0.00% | Add +1155.5% | 506,153 | $1.4M |
| Nantahala Capital Management, LLC | 0.13% | Add +82.1% | 464,367 | $1.3M |
| Cable Car Capital, LP | 1.28% | New | 420,000 | $1.2M |
| Prosight Management, LP | 0.22% | New | 265,000 | $734K |
| Senvest Management, LLC | 0.02% | No change | 230,895 | $576K |
| Geode Capital Management, LLC | 0.00% | Add +144.3% | 170,447 | $472K |
| Sigma Planning Corp | 0.01% | Add +85.7% | 126,225 | $350K |
| Kepos Capital LP | 0.11% | New | 106,000 | $294K |
| Royal Bank of Canada | 0.00% | Add +67.3% | 60,241 | $167K |
| Gagnon Securities LLC | 0.02% | Add +0.1% | 37,977 | $105K |
| BlackRock Inc. | 0.00% | New | 31,285 | $87K |
| Warberg Asset Management LLC | 0.41% | New | 31,354 | $86K |
| Blair William & Co. | 0.00% | Reduce -0.9% | 28,047 | $78K |
| Texas Capital Bank Wealth Management Services Inc | 0.01% | No change | 26,171 | $72K |
| Northern Trust Corp. | 0.00% | New | 25,763 | $71K |
| Renaissance Technologies | 0.00% | Reduce -44.8% | 24,864 | $69K |
| State Street Corp. | 0.00% | New | 10,404 | $29K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +91.3% | 3,864 | $11K |
| UBS Group AG | 0.00% | Add +3281.7% | 3,145 | $9K |
| JFS Wealth Advisors, LLC | 0.00% | No change | 1,590 | $4K |
| US Bancorp \de | 0.00% | No change | 1,250 | $3K |
| Morgan Stanley | 0.00% | No change | 1,250 | $3K |
| Bank of America Corp. | 0.00% | Add +133.6% | 292 | $809 |
| FMR LLC | 0.00% | No change | 233 | $645 |
| Game Plan Financial Advisors, LLC | 0.00% | Reduce -50.0% | 25 | $69 |
| Acadian Asset Management LLC | 0.00% | No change | 17 | $0 |
"% of holder's portfolio" is RNTX's weight in each manager's 13F, not the share of Rein Therapeutics Inc. the manager owns.